The writer and internet critic discusses books that reflect different facets of living in a society run by billionaires.

While Anthropic's dispute with the Pentagon escalated over guardrails on military use, OpenAI LLC struck its own publicized ...

Jack finds great comfort in spending time with Jean. There’s an honesty to her, and he feels understood in a way that he ...

In the race to represent the Republicans in Indiana House District 60, the longtime incumbent sees her mission as continuing ...

MSD is paying $20 million upfront to activate an alliance with Flagship Pioneering's Quotient Therapeutics that will focus on finding new therapeutic targets in inflammatory bowel disease (IBD). The ...

After generating interest from the likes of Pfizer and GSK, Quotient Therapeutics’ somatic genomics platform has attracted another Big Pharma suitor in Merck & Co. Looking to devise new drug targets ...

Lynn Casey is the CEO and founder of Shine Scout: a future trends and consumer insight consultancy working with Fortune 500 companies. AI is undoubtedly the bullet train of our time—fast, relentless, ...

Shelley Zalis: CEO, Founder, and “Chief Troublemaker” of The Female Quotient—is a trailblazing entrepreneur, three-time movement maker, and global advocate for building workplaces that work for ...

For a company founded only four years ago, Quotient Therapeutics Inc. entered its third major deal, this time with Merck & Co. Inc. to find novel drug targets for inflammatory bowel disease (IBD) ...